Clinical Trial Update: Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial comparing pegylated interferon alfa-2b to interferon alfa in adults with essential thrombocythemia; the study status is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Essential Thrombocytopenia | Phase 2 | Status: UNKNOWN